NSF cGMP
Review this document’s named holder, facility scope and current validity. Confirm applicability to the proposed formula and production route.
SLEEPStart Your ProjectA structured quality framework covering raw materials, production, testing, traceability and finished-product documentation.

A supplement manufacturer should identify the facility documents, product specification, production records, batch-specific COA and applicable finished-product testing available for the commercial project.
MITEYO’s Shenzhen team handles sales and research and development. Production is handled by the manufacturing facility. Project review connects the product brief, sampling, production requirements and applicable documentation.
Match supplier qualification documents to the named legal entity, production facility and scope. Confirm product specifications, applicable testing and batch-release documentation for the formula and destination market before production.

Heavy metals testing can be conducted for each commercial production batch according to the approved product specification and destination-market requirements.

Finished-product testing, production records and batch release documentation are confirmed according to the approved project specification.

Official COA documentation is generated for the applicable commercial production batch after finished-product testing and release review.

Stability planning should reflect formula, dosage form, packaging, target market and intended shelf-life strategy.

Review manufacturing-facility documents by holder, scope and validity, then confirm which documents apply to your proposed production project.

Supplier qualification, identity documentation, specifications and receiving controls create the foundation for consistent production.

Documented production processes, in-process checks and batch records help maintain consistency from pilot to commercial scale.

Testing programs can include identity, potency where applicable, microbiological parameters and other product-specific requirements.

Raw materials, production records, packaging components and finished goods should be traceable through controlled batch documentation.
Review the issuing document for its holder, facility scope and validity. The ISO 22000:2018 document shown names GUANGDONG COME HEALTH BIOTECHNOLOGY CO.,LTD. A facility certificate does not certify every formula or destination-market claim. Ask us to match applicable documents to your proposed production project.
Review this document’s named holder, facility scope and current validity. Confirm applicability to the proposed formula and production route.
Review the registered facility and applicable scope. Facility registration is not FDA approval of a product.
Review this document’s named holder, facility scope and current validity. Confirm applicability to the proposed formula and production route.
Review this document’s named holder, facility scope and current validity. Confirm applicability to the proposed formula and production route.
ISO 22000:2018 food-safety management document naming GUANGDONG COME HEALTH BIOTECHNOLOGY CO.,LTD. Verify its facility scope and current validity for the proposed project.
Official COA and applicable finished-product testing are tied to the commercial production batch. They are not presented as generic sample-test results.
Certificate of Analysis generated for the applicable commercial production lot after batch testing and release review.
Lead, arsenic, cadmium and mercury testing can be included for each commercial production batch according to product specification and destination-market requirements.
Finished-product testing, microbiological requirements, production records and supporting release documents are confirmed by project.
Procurement teams can use the quality section to review the types of documentation available for supplier qualification and commercial production.

Official commercial documentation is batch-specific. COA, heavy-metals, microbiological and other finished-product testing should correspond to the approved product specification and destination-market requirements.

Connect manufacturing claims to current organization, facility, product and batch evidence.
Use technical guides to define the evidence required for the actual formula and commercial batch.
Depending on the project, documents may include current facility certifications, approved product specifications, raw-material documentation, batch production records, batch-specific COA, applicable finished-product testing and export documents.
Start with the essentials. Our Shenzhen sales and R&D team coordinates feasibility and commercial review with the production facility.
Your submitted contact and project details are stored in the website inquiry system for MITEYO team follow-up. The submitted page, product context, referrer and campaign parameters may be included to help us understand your request. This form does not automatically send a WhatsApp message. Choosing WhatsApp opens that separate service.
For questions about information you have submitted, contact emma@miteyobio.com.